The American Academy of Neurology (AAN) has developed a new systematic review to summarize for neurologists and other ...

The Tim and Caroline Reynolds Center for Spinal Stimulation at Kessler Foundation has become the first medical center in New ...

An allogeneic stem cell-derived transplant, OPC1 helps restore or increase the functional activity in SCI patients. It is tailored to replace the spinal cord cells that are either ...

More than 15 million people worldwide are living with spinal cord injury (SCI), which can affect their sensory and motor ...

Her injuries have left her with paralysis in her right leg, weakness in her left leg and some degree of paralysis in both ...

Neuvotion announced today that it received FDA 510(k) clearance for its first product, the NeuStim wearable device.

The diagnosis of spinal cord lymphoma is often delayed due to the high risks associated with a spinal cord biopsy, the rarity of the disease, and the lack of specificity of its clinicoradiological ...

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic ...

Neuvotion has received FDA 510(k) clearance for their first product, NeuStim™, a non-invasive, surgery-free wearable that ...

Lineage Cell Therapeutics (LCTX) announced that the Company has initiated the DOSED clinical study. The DOSED study will evaluate the safety ...

A neurosurgeon and a neuroscientist discover promising new ways to help people with spinal cord injuries walk again ...